Brain Death
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Pathologic Function
|
5
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Resectable Pancreatic Ductal Adenocarcinoma
|
disease |
|
Neoplastic Process
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Benign tumor of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
13
|
|
0.300 |
None |
|
0 |
|
|
|
Sleep Deprivation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Finding
|
14
|
|
0.200 |
None |
1.000 |
1 |
|
2013 |
2013 |
Neoplasm of uncertain or unknown behavior of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
41
|
|
0.300 |
None |
|
0 |
|
|
|
Secondary malignant neoplasm of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
69
|
4
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Peutz-Jeghers Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
71
|
79
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
GRN-related frontotemporal dementia
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
112
|
20
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adenocarcinoma, Endometrioid
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
130
|
4
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Ovarian Serous Adenocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
143
|
65
|
0.310 |
None |
1.000 |
1 |
|
2006 |
2006 |
Multiple malignancy
|
phenotype |
Neoplasms
|
Neoplastic Process
|
163
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Progressive supranuclear palsy
|
disease |
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
176
|
52
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Sporadic Parkinson disease
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
179
|
65
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Frontotemporal Lobar Degeneration
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
195
|
54
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Breast adenocarcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
219
|
7
|
0.300 |
None |
|
0 |
|
|
|
Carcinoma, Endometrioid
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
223
|
12
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2011 |
Disseminated Malignant Neoplasm
|
phenotype |
Neoplasms
|
Neoplastic Process
|
232
|
4
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Transient Ischemic Attack
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
344
|
16
|
0.200 |
None |
1.000 |
1 |
|
1997 |
1997 |
Stage 0 Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stage IIB Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stage III Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stage IV Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Epstein-Barr Virus Infections
|
group |
Infections
|
Disease or Syndrome
|
384
|
72
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Metastatic malignant neoplasm to brain
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
392
|
28
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |